Literature DB >> 12014216

EDTA-dependent pseudothrombocytopenia confirmed by supplementation of kanamycin; a case report.

Hae Lyun Ahn1, Young Il Jo, Young Suk Choi, Jung Yeon Lee, Hae Woon Lee, Seong Ryul Kim, Joon Sim, Weon Lee, Chun Jo Jin.   

Abstract

EDTA-dependent pseudothrombocytopenia (PTCP) is the phenomenon of a spurious low platelet count due to EDTA-induced aggregation of platelets. Since the failure to recognize EDTA-dependent PTCP may result in incorrect diagnosis and inappropriate treatment, the recognition of this phenomenon is very important. We report an insidious case of EDTA-dependent PTCP confirmed by supplementation of kanamycin to anticoagulant in a 53-year-old women. Although sodium citrate and heparin usually prevented the aggregation of platelets in EDTA-dependent PTCP patients, these anticoagulants failed in preventing PTCP in our case. EDTA-dependent PTCP was confirmed by the findings that the clumping of platelets on microscopic evaluation was found in EDTA-anticoagulated blood samples, whereas thrombocytopenia and platelet aggregation were not revealed in the sample supplemented with kanamycin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12014216      PMCID: PMC4531650          DOI: 10.3904/kjim.2002.17.1.65

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  14 in total

1.  Accurate platelet counting in an insidious case of pseudothrombocytopenia.

Authors:  A J Lombarts; J J Zijlstra; R H Peters; C G Thomasson; P F Franck
Journal:  Clin Chem Lab Med       Date:  1999 Nov-Dec       Impact factor: 3.694

Review 2.  EDTA-dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature.

Authors:  N Berkman; Y Michaeli; R Or; A Eldor
Journal:  Am J Hematol       Date:  1991-03       Impact factor: 10.047

3.  Documented sudden onset of pseudothrombocytopenia.

Authors:  M E Gschwandtner; P Siostrzonek; C Bodinger; T Neunteufl; C Zauner; G Heinz; G Maurer; S Panzer
Journal:  Ann Hematol       Date:  1997-06       Impact factor: 3.673

4.  Sudden onset of EDTA-dependent pseudothrombocytopenia after therapy with the glycoprotein IIb/IIIa antagonist c7E3 Fab.

Authors:  H Stiegler; Y Fischer; S Steiner; B E Strauer; H Reinauer
Journal:  Ann Hematol       Date:  2000-03       Impact factor: 3.673

5.  "Correct" platelet count in EDTA-dependent pseudothrombocytopenia.

Authors:  O Kabutomori; Y Iwatani
Journal:  Eur J Haematol       Date:  1995-07       Impact factor: 2.997

6.  EDTA-dependent pseudothrombocytopenia. Association with antiplatelet and antiphospholipid antibodies.

Authors:  N Bizzaro; M Brandalise
Journal:  Am J Clin Pathol       Date:  1995-01       Impact factor: 2.493

7.  Pseudoleukocytosis due to EDTA-induced platelet clumping.

Authors:  R A Savage
Journal:  Am J Clin Pathol       Date:  1984-03       Impact factor: 2.493

8.  Transient EDTA-dependent pseudothrombocytopenia in a patient with sepsis.

Authors:  M Mori; H Kudo; S Yoshitake; K Ito; C Shinguu; T Noguchi
Journal:  Intensive Care Med       Date:  2000-02       Impact factor: 17.440

9.  Sequential measurement of anti-platelet antibodies in a patient who developed EDTA-dependent pseudothrombocytopenia.

Authors:  B Edelman; T Kickler
Journal:  Am J Clin Pathol       Date:  1993-01       Impact factor: 2.493

10.  Recognition and prevention of pseudothrombocytopenia and concomitant pseudoleukocytosis.

Authors:  A J Lombarts; W de Kieviet
Journal:  Am J Clin Pathol       Date:  1988-05       Impact factor: 2.493

View more
  6 in total

1.  Discovery and Correction of Spurious Low Platelet Counts due to EDTA-Dependent Pseudothrombocytopenia.

Authors:  Jianhua Lin; Yaoling Luo; Shaoyu Yao; Miansheng Yan; Jianpei Li; Wenting Ouyang; Miaohuan Kuang
Journal:  J Clin Lab Anal       Date:  2014-11-25       Impact factor: 2.352

2.  Effective estimation of correct platelet counts in pseudothrombocytopenia using an alternative anticoagulant based on magnesium salt.

Authors:  Peter Schuff-Werner; Michael Steiner; Sebastian Fenger; Hans-Jürgen Gross; Alexa Bierlich; Katrin Dreissiger; Steffen Mannuß; Gabriele Siegert; Maximilian Bachem; Peter Kohlschein
Journal:  Br J Haematol       Date:  2013-06-29       Impact factor: 6.998

Review 3.  Pseudothrombocytopenia-A Review on Causes, Occurrence and Clinical Implications.

Authors:  Benjamin Lardinois; Julien Favresse; Bernard Chatelain; Giuseppe Lippi; François Mullier
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241

Review 4.  Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism.

Authors:  Piotr Rzymski; Bartłomiej Perek; Robert Flisiak
Journal:  Vaccines (Basel)       Date:  2021-05-27

Review 5.  Estimation of Platelet Counts and Other Hematological Parameters in Pseudothrombocytopenia Using Alternative Anticoagulant: Magnesium Sulfate.

Authors:  Chidambharam Choccalingam; Rajesh Kanna Nandagopal Radha; Nadella Snigdha
Journal:  Clin Med Insights Blood Disord       Date:  2017-04-24

6.  A Curious Case of Pseudothrombocytopenia due to In Vitro Agglutination.

Authors:  Le Zhong; Juskaran Chadha; Ali Ameri
Journal:  Case Rep Hematol       Date:  2020-02-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.